MEDICSCOVER LTD
Company number 12926152 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MEDICSCOVER LTD - Analysis Report
Company Number: 12926152
Analysis Date: 2025-07-29 17:40 UTC
Financial Health Assessment Report for MEDICSCOVER LTD
1. Financial Health Score: B
Explanation:
MEDICSCOVER LTD demonstrates a solid financial footing for a micro-entity, with steadily increasing net assets and strong liquidity. The company has no signs of financial distress or overdue filings, indicating good compliance and operational management. However, limited fixed assets and a relatively small share capital suggest some vulnerability to external shocks or rapid scale-up needs. Hence, a "B" grade reflects a generally healthy but cautious outlook.
2. Key Vital Signs
| Metric | 2023 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 636 | Modest investment in long-term assets; typical for a micro entity. |
| Current Assets | 35,535 | Healthy level of liquid assets, primarily cash or receivables. |
| Current Liabilities | 5,946 | Low short-term debt, manageable obligations. |
| Net Current Assets | 29,589 | Strong working capital; "healthy cash flow" potential. |
| Net Assets (Shareholders Funds) | 30,225 | Positive equity base, increasing year-on-year, indicating retained profitability or capital injections. |
| Share Capital | 1 | Minimal share capital, typical for micro companies but limits financial buffer. |
| Average Employees | 2 | Small workforce, consistent with micro-entity status. |
| Filing Status | Up to date | No overdue accounts or returns, reflecting good compliance. |
Trend Analysis:
- Net assets increased from £5,957 in 2020 to £30,225 in 2023, over a five-fold increase, indicating growing retained earnings or capital support.
- Current assets nearly tripled from £11,421 in 2020 to £35,535 in 2023, showing improved liquidity and operational cash flow.
- Current liabilities increased but remain low relative to current assets, maintaining strong net current assets.
3. Diagnosis
Like a patient with robust vital signs but limited reserves, MEDICSCOVER LTD shows "symptoms" of a growing and well-managed business. The company's liquidity is strong, indicating a healthy cash flow cycle and capacity to meet short-term debts comfortably. The stability and increase in net assets suggest profitable operations or capital injections, which strengthen the business's financial resilience.
However, the very low share capital and minimal fixed assets reveal a "lean build" with limited physical or financial buffers. This could mean the company is asset-light, relying on service delivery (hospital activities) rather than capital-intensive operations. While not a cause for immediate concern, it flags a vulnerability to sudden operational disruptions or economic shocks.
The absence of overdue filings and consistent directorship with no disqualification records aligns with good governance and regulatory compliance, vital signs of a healthy corporate "immune system."
4. Recommendations
Build Financial Buffers:
Consider increasing share capital or retaining more earnings to build a stronger equity base. This will provide a cushion against unforeseen risks or facilitate growth investments.Monitor Cash Flow Regularly:
Maintain diligent cash flow forecasting to sustain the strong working capital position. Avoid sudden spikes in current liabilities that could stress liquidity.Invest in Fixed Assets Judiciously:
Evaluate opportunities to invest in fixed assets that can enhance operational capacity or efficiency, but balance this against the risk of overextending financially.Plan for Growth:
As a micro-entity with increasing activity (noted by the doubling of employees), prepare strategic plans for scaling operations, including possibly moving into small company status with more robust financial reporting.Continue Compliance Vigilance:
Keep filing deadlines and governance intact to avoid penalties or reputational damage.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.